Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Abroad (travel likely)Recruiting

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cardiac Research Office, Aberdeen Royal Infirmary, Aberdeen, Aberdeenshire, United Kingdom
Contact: Study coordinator (Dana Dawson, PhD) · dana.dawson@abdn.ac.uk · 01224 437969
Contact: Study coordinator (Amelia Rudd, HND) · a.e.rudd@abdn.ac.uk · 01224 559573
University of Aberdeen, Aberdeen, United Kingdom
Contact: Study coordinator (Sylvia Kamya, MBChB) · sylvia.kamya@nhs.scot · +441224559573
Contact: Study coordinator (Amelia Rudd, PhD) · a.e.rudd@abdn.ac.uk
Contact: Principal Investigator (Dana K Dawson, MPhil)

Study leads

Dana Dawson, MPhil
Principal Investigator
University of Aberdeen

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Skipping Hormone Therapy in Low-Risk Early Breast Cancer

Breast Cancer (Early Breast Cancer)

Abroad (travel likely)RecruitingPHASE2

Angers, France · Avignon, France

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Colitis · Diarrhea · Malignant Genitourinary System Neoplasm

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer

Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE2

St Louis, United States · East Providence, United States

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

HER2 + Breast Cancer · Advanced Breast Cancer

Abroad (travel likely)RecruitingPHASE4

Beijing, China